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ABSTRACT
We have studied the consequences of two homo-
plasmic, pathogenic point mutations (T7512C and
G7497A) in the tRNA
Ser(UCN) gene of mitochondrial
(mt) DNA using osteosarcoma cybrids. We identified
a severe reduction of tRNA
Ser(UCN) to levels below
10% of controls for both mutations, resulting in a
40% reduction in mitochondrial protein synthesis
rate and in a respiratory chain deficiency resembl-
ing that in the patients muscle. Aminoacylation was
apparentlyunaffected.Onnon-denaturatingnorthern
blots we detected an altered electrophoretic mobility
for G7497A containing tRNA molecules suggesting a
structural impact of this mutation, which was con-
firmed by structural probing. By comparing in vitro
transcribed molecules with native RNA in such gels,
we also identified tRNA
Ser(UCN) being present in two
isoforms in vivo, probably corresponding to the
nascent, unmodified transcripts co-migrating with
the in vitro transcripts and a second, faster moving
isoformcorrespondingtothematuretRNA.Incybrids
containing either mutations the unmodified iso-
forms were severely reduced. We hypothesize that
both mutations lead to an impairment of post-
transcriptional modification processes, ultimately
leading to a preponderance of degradation by nucle-
ases over maturation by modifying enzymes, result-
ing in severely reduced tRNA
Ser(UCN) steady state
levels. We infer that an increased degradation rate,
caused by disturbance of tRNA maturation and,
in the case of the G7497A mutant, alteration of
tRNA structure, is a new pathogenic mechanism
of mt tRNA point mutations.
INTRODUCTION
Mitochondrial DNA (mtDNA) codes for a total of 37 genes
and different human mtDNA alterations, including rearrange-
ments as well as mutations in most of them have been iden-
tiﬁed as underlying various clinical diseases. In fact, point
mutations are responsible for a tremendous number of differ-
ent clinical phenotypes. This variability has been related to
the peculiarities of mitochondrial genetics, e.g. (i) random
segregation of a given mutation within the human body,
(ii)heteroplasmy,i.e.thecoexistenceofwild-typeandmutated
mtDNA molecules within mitochondria, cells and tissues and
(iii) threshold effects, meaning that a given mutation becomes
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doi:10.1093/nar/gki876functionally relevant only if it exceeds a certain level of
heteroplasmy. However, it has become clear that beyond
those characteristics mtDNA point-mutations may have
quite variable consequences on the genuine function of the
corresponding protein, tRNA or rRNA, and several patterns of
those consequences have been identiﬁed in the last years (1,2).
It is tempting to speculate that these different pathome-
chanisms not only discriminate, whether a given base pair
substitution results in either a functionally irrelevant silent
polymorphism or in a potentially disease causing point-
mutation, they most likely contribute as well to the quite
variable clinical phenotypes of point mutations in any mito-
chondrial gene. This is particularly true for the 22 tRNA
genes where mutations are causing more complex processes
than the simple alternative between an either fully functional
tRNA or a molecule which is not participating at all in the
translational process. Several different pathomechanisms at
different levels of cellular function have been identiﬁed in
the last years: point mutations may reduce the steady state
levels of the corresponding tRNA (3), may interfere with
the level of aminoacylation with the corresponding amino
acid (4), induce an atypical base-modiﬁcation pattern (5)
and may result in quantitative and/or qualitative alterations
of protein synthesis and respiratory chain (RC) function (6,7).
Structure, as the basis for all biochemical function, repres-
ents a common factor that potentially can be affected by any
mutation, and which may have detrimental effects to any num-
ber of biochemical interactions. Thus, structural perturbation
of tRNAs by pathogenic point mutations represents a poten-
tially signiﬁcant pathomechanism.
Consequently, structural inﬂuence of pathogenic mutation
has been investigated in several cases [(8–11), reviewed in
(1)]. Because of the central role of tRNAs in protein biosyn-
thesis, and their multiple interactions with a large number of
different factors, special considerations are warranted when
tRNA structure isexamined. Two principle possibilities canbe
considered: either a mutation does affect the tRNA structure
only in the immediate vicinity of the mutation, leaving the
general tRNA structure intact, or on the contrary, it severely
affects tRNA structure. In the former case, the pathogenic
effect is likely to be restricted to the interaction with a single
or a few factors, e.g. interfering with aminoacylation if an
identity element for tRNA is affected. In the latter case,
when the mutated residue represents an important component
of tRNA architecture, detrimental effects can be awaited on
most of the interactions with other biomolecules. So far, only
mild to moderate structural impacts of pathogenic mutat-
ions have been described (9). This is not surprising, since
serious consequences of signiﬁcant structural perturbations
are likely to cause a strong negative selection pressure on the
affected cell.
We have studied the consequences of two pathogenic point
mutations (T7512C and G7497A, Supplementary Figure 1) in
the tRNA
Ser(UCN)geneusingosteosarcomacellcybridsincorp-
orating both mutations at homoplasmic levels and observed
that both mutations lead to extremely reduced steady state
levels of tRNA
Ser(UCN). The biochemical consequences are
signiﬁcant disturbances of mitochondrial protein synthesis
and a marked deﬁciency of complexes I and IV, reproducing
the biochemical phenotype in the patients who presented
with these mutations which cause serious disease (12).
Interestingly, the tRNAs, although present at low levels,
are functional regarding aminoacylation in both mutants.
Non-denaturing gel electrophoresis comparing in vitro tran-
scripts to RNA extracted from cybrids suggests that both
mutations lead to a defect of maturation from unmodiﬁed
to mature tRNA molecules in vivo, i.e. a prevailance of
degradation over maturation. For the T7512C mutation, a pro-
cessing defect of a precursor transcript may also be involved.
MATERIALS AND METHODS
Patients
Both patients have already been described (12). In brief, a boy
with the G7497A mutation presented at age 3 years with
increased exercise intolerance. He showed elevated lactate
levels in plasma and cerebrospinal ﬂuid as well as ragged
red ﬁbres (RRF) in a muscle biopsy. Meanwhile he developed
as well sensorineural deafness. The patient with the T7512C
mutation was a boy initially presenting in his ﬁrst year of life
with sensorineural deafness and showing at the age of 6 years
myoclonic jerks, dystonic posturing, inability to walk and
marked psychomotor retardation including loss of acquired
skills. He had no lactic acidosis and no RRF in his muscle
biopsy either. Both patients showed a combined RC deﬁciency
of complexes I and IV in muscle (12).
Generation of cybrid cell lines and culture of cells
Cybrid cell lines were constructed by intercellular transfer of
patient mtDNA from patient skin ﬁbroblasts to rho
0 143B cells
(TK-, subclone rho
0 206) (13). Patient ﬁbroblasts were enuc-
leated using cytochalasin B and then fused with rho
0 cells in
the presence of polyethylene glycol. The cybrid cells were
cultivated in DMEM containing 4.5 g/l glucose supplemented
with 5% fetal calf serum (FCS), Glutamax I, 1 mM sodium
pyruvate, 100 mg/ml uridine, 100 U/ml penicillin and
100 mg/ml streptomycin. Single clones were isolated by the
cylinder method. For the T7512C mutation a total number of
60 clones, for the G7497A mutation 75 clones were obtained
by one fusion experiment.
In order to analyse the rate of degradation of mitochondrial
transcripts, 3 · 10
5 cells were seeded in small dishes, the
medium was changed after 24 h and cells were further
grown in the presence of ethidium bromide (250 ng/ml) for
24 h or up to 48 h before extraction of RNA. In order to
estimate the rates of synthesis of mitochondrial transcripts,
cells pre-treated with EtBr for 24 or 48 h were washed
extensively to remove the drug and cultivated for another
48 or 96 h.
Fibroblasts of healthy control individuals as well as from
both patients were cultivated in RPMI 1640 with Glutamax
supplemented with 10% FCS, 200 mM Uridine, 2.5 mM
sodium pyruvate, 100 mg/ml Streptomycin and 100 IU/ml
Penicillin at 37 C and 5% CO2.
Validation of the genotype of cybrid clones
In the case of the G7497A mutation, a 926 bp DNA fragment
spanning the completetRNA
Ser(UCN)gene was ampliﬁed (Sup-
plementary Figure 2A). Within this fragment the G7497A
mutation deletes one of two restriction sites for the restriction
endonuclease HaeIII. Digestion of the PCR product by HaeIII
5648 Nucleic Acids Research, 2005, Vol. 33, No. 17yielded a total number of three fragments of the expected size
in control samples and in the 143B acceptor cell line, while
patient ﬁbroblasts and the all clones showed only two DNA
fragments.
Using a similar strategy, a DNA fragment of 175 bp was
ampliﬁedfortheT7512Cmutation(SupplementaryFigure2B).
The reverse primer introduced by mismatch a novel restriction
site for XhoI in the PCR product if derived from the mutated
template. Digestion by XhoI yielded only fragments of the
predicted smaller size in all clones, while PCR products
derived from controls and 143B acceptor cells remaineduncut.
Oligonucleotides used for detection of G7497A mutation
were: ‘mt6961s’: ATC GGC ATT GTA TTA GCA AAC,
‘mt7887as’: CCA ATT GAT TTG ATG GTA AGG and for
detection of the T7512C mutation ‘mt7375s’: ACC TGG AGT
GAC TAT ATG GAT G and ‘mt7550as’: GAC AAA GTT
ATG AAA TGG TTT TTC TAA TAC CTT CTC GA.
The nuclear background of all generated cybrid clones was
evaluated by ampliﬁcation of a polymorphic marker on chro-
mosome 11q13 (D11S533) (14) using the following oligonuc-
leotides: ‘D11S533s’: GCC TAG TCC CTG GGT GTG GTC,
‘D11S533as’: GGG GGT CTG GGA ACA TGT CCC C.
Oxygen consumption studies and respiratory chain
enzyme assays
All cells were grown until they were  80% conﬂuent. The
growth medium was changed the day before harvesting. The
ﬁnal cell pellet contained 10
6–10
7 cells and was resuspended
in phosphate-buffered saline (PBS). The resulting cell suspen-
sion was then used in part for oxygen consumption studies and
was in part frozen for further spectrophotometric assays. The
cellular density of the suspension was evaluated by automated
counting (CASY, Scha ¨rfe Systems, Reutlingen, Germany)
while the protein content was determined by Bradford assay
(BioRad, Mu ¨nchen, Germany). Oxygen consumption of intact
cells reﬂecting the metabolism of endogenous substrates was
measured within a short and constant time after harvesting
using two Clark oxygen electrodes (Hansatech Instruments
Limited, King’s Lynn, UK). Intact cell respiration was ﬁrst
recorded and then after permeabilization with digitonine the
rates for pyruvate (+malate), malate (+glutamate), suc-
cinate and glycero-3-phosphate as substrates were deter-
mined. Spectrophotometric studies were performed using a
Beckmann DU-600 spectrophotometer (Beckmann Instru-
ments, Fullerton, CA) in order to determine the RC enzyme
activities of Succinate-cytochrome c Reductase (SCCR, com-
plex II and III), Quinol-cytochrome c Reductase (QCCR, com-
plex III), cytochrome c Oxidase (COX, complex IV) as well as
Citrate Synthase (CS) and Lactate Dehydrogenase (LDH)
as reference enzymes. Both methods were performed as
described in detail (15).
Northern blots
Total RNA was isolated from  2 · 10
6 cultured cells using
Trizol reagent (Invitrogen, Karlsruhe, Germany).
For the analysis of tRNA levels, synthesis and stability,
samples of 0.5 mg total RNA were denatured (100 C for
5 min) and then subjected to electrophoresis through 8%
denaturing polyacrylamide gels containing 8 M urea using
1· TBE as gel and running buffer. Separated samples were
electroblotted onto Nylon membranes in 0.25· TBE and
immobilized by incubation at 80 C for 2 h.
Analysis of precursor transcripts was carried out by separ-
ating 3 mg of total RNA through 1.2% agarose gels containing
6.5% formaldehyde and 1· MOPS buffer using 1· MOPS as a
running buffer (16). Separated samples were capillary blotted
onto Nylon membranes in 10· SSPE and immobilized by
incubation at 80 C for 2 h.
For the analysis of tRNA structure, unheated samples of
0.5–3 mg total RNA were subjected to electrophoresis through
a 8% non-denaturing polyacrylamide gel using 1· TBE as
gel and running buffer. Blotting and immobilization was
performed as before.
Aminoacylation levels of tRNAs were analysed under
acidic conditions as described previously (17). RNA was isol-
ated using Trizol reagent, however, it was ensured that sam-
ples were kept on ice during the procedure and the ﬁnal RNA
pellet was resuspended in 0.3 M sodium acetate (pH 4.5) and
1 mM EDTA. A total of 10 mg of acidic RNA were elec-
trophoresed through a 6.5% acidic denaturing polyacrylamide
gel (20 · 43 cm and 1 mm thick) containing 8 M urea and
0.1 M sodium acetate/0.1 M acetic acid (pH 5.0) as running
buffer at 4 C and 30 mA over 48 h. Final running distance of
xylenecyanol was 23 cm. Deacylation of individual RNA
samples was carried out in 0.3 M Tris–HCl (pH 9.0), at 75 C
for15 min. Separated sampleswere electroblotted andimmob-
ilized onto Nylon membranes as described above.
Regions of mtDNA encompassing various mRNA and
tRNA genes were used as probes for the northern blots.
Several probes were generated by PCR using the following
forward and reverse primers. For ND1: ‘mt3384s’: AAT TCT
AGG CTA TAT ACA AC and ‘mt7395as’: ATC CAT ATA
GTC ACT CCA, which was digested to give speciﬁc probes
for ND1, ND2 and COI; for ND5/6: ‘mt14330s’: ACA ACC
ACC ACC CCA TCA and ‘mt14613as’: TCT AAG CCT TCT
CCT ATT T; for tRNA
Leu(UUR): ‘mt3232s’: TAA GAT GGC
AGA GCC CG and ‘mt3305as’: TAA TAC GAC TCA CTA
TAT TGT TAA GAA GAG GAA TTG; for tRNA
Val:
‘mt1602s’: CAG AGT GTA GCT TAA CAC AAA and
‘mt1670as’: TCA GAG CGG TCA AGT TAA. As template
for the PCR reaction DNA derived from 143B control cells
was used. PCR products were puriﬁed (QIAquick PCR
puriﬁcation columns, Qiagen, Hilden, Germany) and then
radiolabelled with [a-
32P]dCTP (5000 Ci/mmol) by the
random-priming method, while unincorporated nucleotides
were removed by gel ﬁltration through ChromaSpin columns
(Clontech, Heidelberg, Germany). The probe against the 18S
non-mt rRNA was a 5.8 kb insert in pBS-18S released by
EcoRI (18) and was labelled as well by random-priming.
50 end labelling was applied using [g-
32P]ATP (3000 Ci/
mmol) for the following probes: for tRNA
Ser (UCN): ‘mt7478s’:
GGT TTC AAG CCA ACC CCA TGG CCT C; for tRNA
Lys:
‘mt8364as’: TCA CTG TAA AGA GGT GTT GGT TCT C;
for tRNA
Gln: ‘mt4329s’: CTA GGA CTA TGA GAA TCG
AA. For the normalization of tRNAs to a non-mtRNA
species blots were hybridized with an end-labelled 5S rRNA
probe: GGG TGG TAT GGC CGT AGA C (5). Puriﬁcation
and gel ﬁltration was performed for end-labelled probes
accordingly.
Hybridization was carried out at 65 C (exceptions: 45 C:
tRNA
Gln;5 0  C: ND1, tRNA
Ser(UCN);5 5  C: tRNA
Leu(UUR))
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sulfate and 1 M NaCl containing 2 · 10
6 c.p.m. radiolabelled
probe +4 mg sonicated salmon sperm DNA. After hybridiza-
tion, two 10 min washes were performed at 45  to 65 C with
2· SSC and 0.1% SDS, followed by a 3–10 min wash at 45  to
65 C with 0.1 · SSC, 0.1% SDS. Blots were subjected to
PhosphorImager analysis or autoradiography.
Synthesis and structural probing of
in vitro transcripts
Templates for in vitro transcription were ampliﬁed by PCR
from a synthetic single stranded 144mer DNA encoding a
hammerhead ribozyme downstream of a T7-promotor and
followed by the sequence of human mt tRNA
Ser(UCN) or its
respective mutants. Upon transcription with T7-RNA poly-
merase, the hammerhead ribozyme cleaves at its designated
target site to release the tRNA sequence with a 50-hydroxyl-
end (19). After puriﬁcation over a 12% 8 M urea PAGE,
transcripts were passively eluted by agitation in 0.5 M
NH4OAc. 50-labelling with [g-
32P]ATP and T4-PNK and sub-
sequent puriﬁcation by PAGE were performed as described
(20). 30-labelling was done by the splint labelling method (21).
To detect secondary cleavages, experiments were performed
on transcripts labelled on the 50-extremity, as well as on tran-
scripts labelled on the 30-extremity. Structural probing with
nucleases was done at 35 C as described (20). Since enzyme
activities were found to vary greatly over time and among
different manufacturers, nuclease concentrations were optim-
ized before every set of experiments, and enzyme dilutions
were freshly prepared from stock solutions.
Analysis of mitochondrial protein synthesis
For measurement of protein synthesis, subconﬂuent cells
grown in 12-well plates or 6 cm dishes were washed
twice with methionine free medium, then 500 ml or 5 ml,
respectively, of methionine free medium containing 10% of
dialysed FCS and 100 mg/ml of emetine was added (22) and
the incubation was continued for 6 min at 37 C and 5% CO2.
A total of 0.5 mCi of [
35S]methionine (Hartmann Analytic,
Braunschweig, Germany) were added and the cells were
incubated for up to 120 min in initial experiments at 37 C
and 5% CO2. Cells were harvested and labelled protein was
precipitated by 10% TCA on glass ﬁber ﬁlters, unincorporated
[
35S]methionine was removed by extensive washing and
incorporation was analysed by liquid scintillation counting
(12-well plates). Incorporation into total cell protein in the
absence of emetine was linear for 2 h, while incorporation
inthepresenceofemetineincreasedlinearly upto60min(data
not shown). Thus, measurement of mitochondrial protein
synthesis rates was assayed in the following experiments by
analyzing the incorporation into mitochondrial proteins after
45 min. For this purpose, cells (6 cm dishes) were lysed in
TOTEX buffer [20 mM HEPES (pH 7.9), 400 mM NaCl, 20%
Glycerol, 1% NP-40, 1 mM MgCl2, 0.5 mM EDTA, 0.1 mM
EGTA, 10 mM b-Glycerophosphate, 10 mM NaF, 5 mM DTT,
0.5mM Na3VO4, and 1 mM PMSF] and labelled proteins were
analysed by SDS–PAGE (23). Gels were Coomassie stained,
dried and exposed to X-ray ﬁlms. Autoradiographs were
scanned with a densitometer, and the densitometric values
obtained forall bands were normalizedtothe respective values
obtained by densitometric scanning of the Coomassie stain.
RESULTS
All generated cybrid clones contain the mutation at
homoplasmic level
A considerable number of cybrid clones from either mutation
were generated and the mitochondrial genotype of several
clones was veriﬁed (n ¼ 15 for G7497A and n ¼ 22 for
T7512C). Restriction fragment length analysis showed that
all clones, but also the patients ﬁbroblasts were homoplasmic
for the two mutations within the detection limits of this
method (Supplementary Figure 2A and B).
The complete absence of patient-derived nuclear DNA was
conﬁrmed in all clones used for further studies.A polymorphic
marker for nuclear DNA D11S533, (14) was ampliﬁed and
found to be informative: In all 143B control cells, 143B rho
0
acceptor cells and all tested clones ampliﬁcation yielded only
one fragment of a given size while ampliﬁcation in the two
patient ﬁbroblast cell lines yielded one or two fragments, in
both cases of a different size. This conﬁrmed successful cybrid
generation and homogeneity of 143B-derived nuclear DNA in
all clones (Supplementary Figure 2C).
The cybrid clones show a combined deficiency of
respiratory chain complexes I and IV like the
patients in vivo
The biochemical phenotype of the generated cybrid cell lines
was then characterized by two different methods. Three dif-
ferent clones were tested for either mutation and compared to
143B cell lines as control. Oxygen consumption of intact cells
reﬂecting the metabolism of endogenous substrates showed a
clear decrease in all clones of either mutation (Figure 1A).
After permeabilization by digitonin, the oxygen consumption
rates of those substrates which feed their electrons into the RC
via complex I, i.e. pyruvate (in the presence of malate) and
malate (in the presence of glutamate), were likewise clearly
decreased. On the other hand, oxygen consumption in the
presence of those substrates which feed their electrons distal
from complex I into the RC, e.g. succinate and glycero-
3-phosphate, via complex II and Glycero-3-Phosphate-
Dehydrogenase directly into the pool of quinones respectively,
were much less affected compared to controls. This is a clear
evidence for a complex I deﬁciency (15,24). However, as in
this experimental setting the activity of COX (complex IV)
is not rate-limiting over a considerable range, an additional
deﬁciency of this complex cannot be ruled out based on these
results.
Therefore we next performed spectrophotometric assays on
the freeze-thawed cell homogenates which were used before
in the polarographic studies. We were able to identify a clear
COX deﬁciency in all tested clones of either mutation
(Figure 1B). The activities of SCCR (complexes II and III)
and of QCCR (complex III) were not signiﬁcantly reduced
when compared to controls, in particular when looking at
activity ratios (Figure 1B).
Therefore, in our cybrid cell lines we identiﬁed a combined
deﬁciency of complexes I and IV of the respiratory chain by
5650 Nucleic Acids Research, 2005, Vol. 33, No. 17either mutation, reproducing the biochemical phenotype found
in muscle tissue of both patients (12).
Strong reduction of the tRNA
Ser(UCN) steady state levels
in clones of both mutations
In order to test the potential effects of both mutations on
synthesis,stability,structureandfunctionofthe tRNA
Ser(UCN),
a series of northern blots under different electrophoretic con-
ditions was performed.
First, RNA was extracted from cybrid and control cell lines
and fractionated on denaturing, urea-containing polyacry-
lamide gels (Figure 2). Steady state levels of tRNA
Ser(UCN)
were markedly decreased in all clones of either mutation:
when normalized to nuclear encoded 5S rRNA as loading
control, steady state levels were calculated to be between
2% (G7497A) and 6% (T7512C) of controls. Steady state
levels for tRNA
Val, tRNA
Leu(UUR) and tRNA
Gln, representing
othertRNA genesontheheavyandonthelightstrand,respect-
ively, were found to be unchanged (Figure 2). Moreover, a
similar pronounced depletion was detected in RNA samples
extracted from ﬁbroblasts of either patient, demonstrating the
relevance of our cybrid models for the analysis of the patho-
genetic mechanisms of these two mutations.
No accumulation of high molecular weight
precursor transcripts
A decreased steady state level of mutated tRNA
Ser(UCN) could
either result from deﬁcient synthesis of the mtDNA light
strand, from a decreasedprocessing rate of larger polycistronic
RNA units or from increased degradation of correctly pro-
cessed but otherwise affected tRNA. To test for abnormal
processing, in a ﬁrst approach we looked for high molecular
weight unprocessed intermediates using different double-
stranded probes for both, heavy strand and light strand tran-
scripts. Neither ND1 nor ND6/5 probes did reveal different
RNA precursors present in either of the clones compared to
controls (Figure 3) on these agarose gels. Steady state levels of
ND5 and ND1 mRNA were unchanged when compared to 18S
rRNA and ND6 mRNA was not visible due to its low abund-
ance. However, we did see low molecular weight unprocessed
precursors on non-denaturing PAGE gels in clones harbouring
the T7512C mutation (see below).
Synthesis and stability of tRNA
Ser(UCN) are not
considerably altered by either mutation
We next sought to analyse stability as well as the rate of
synthesis of tRNA
Ser(UCN). In a ﬁrst approach, we followed
A
B
Figure1.Respiratorychainphenotypeofcybridcelllines.(A)Polarography.GraphsshowmeanvaluesandSDsforoxygenconsumptionof143Bcontrolcells(solid
bars,n ¼ 10)andofthreedifferentclonescontainingeithermutation(patternedbars,n > 3foreachclone)inintactcellsandrespiringonindicatedsubstratesafter
permeabilization. (Glut ¼ glutamate). (B) Respiratory chain complex activities. Graphs show SCCR (complex II and III), COX (complex IV) and CS as
mitochondrial matrix marker (left panel) and their activity ratios (right panel). Graphs are mean values and SDs for 143B control cells (solid bars, n ¼ 5). Enzyme
activities were measured only once in each of three different clones containing either mutation.
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a 48 h period of treatment with ethidium bromide (EtBr),
respectively, on denaturing PAGE gels (data not shown).
However, due to the very low initial levels the scattering of
data precluded the calculation of convincing values for true
doubling times or half-lifes of tRNA
Ser(UCN), respectively. In a
separate set of experiments, stability and synthesis were thus
assessed by measuring steady state levels of tRNA
Ser(UCN)
after a single 24 h period of EtBr treatment and 48 h after
withdrawal of EtBr, referring at all time points to the
pre-treatment levels (Supplementary Figure 3). Steady state
levels of tRNA
Ser(UCN) were reduced quite evenly to 57, 67
and 65% of pre-treatment levels for 143B wild-type controls,
Clone #2 (7497) and Clone #7 (7512), respectively, after 24 h
of treatment. Likewise, we were not able to see major differ-
ences in steady state levels reached 48 h after withdrawal
of EtBr which were calculated as 67, 75 and 84% for 143B
wild-type controls, Clone #2 (7497) and Clone #7 (7512),
respectively.
Electrophoretic migration properties of tRNA
Ser(UCN)
are altered by the G7497 mutation per se and suggest
defects in post-transcriptional modification
When RNA was run under non-denaturing conditions, we
found that the G7497A mutation lead to an acceleration of
electrophoretic mobility of tRNA
Ser(UCN) (Figure 4A) while
the T7512C mutation lead to a rather similar mobility com-
pared to control. Furthermore, all tRNA
Ser(UCN) molecules
were present in at least two different conformations. These
isoforms do not correspond to the acylated and non-acylated
forms as the alkaline pH of the gel system used leads to
deacylation. Rather, as all examined tRNA
Ser(UCN) derivatives
display the same electrophoretic mobility in denaturing PAGE
systems (Figures 2 and 7), the existence of differently migrat-
ing isoforms can be attributed to structural changes induced by
post-transcriptional modiﬁcations.
In order to investigate whether the mutations alone are
sufﬁcient to cause an alteration of electrophoretic mobility
and how post-transcriptional modiﬁcation is involved, in
vitro tRNA
Ser(UCN) transcripts were generated to compare
the mobilities of unmodiﬁed transcripts with their native,
modiﬁed counterparts isolated from cybrid cells (Figure 4B).
In this blot, only 1/10 of RNA was loaded from control cells in
order to facilitate comparison with the much less abundant
tRNA
Ser(UCN) incybridclones.Inall cybrid samples twobands
Figure 2. Analysisof tRNAlevelsby denaturingPAGE and northernblotting.RNA isolatedfromfibroblastsofboth patientsand from threehealthy controls,from
threedifferentcybridclonescontainingeithermutationaswellasfrom143Bcellsandtwocontrolcybridcelllineswererununderdenaturingconditions,blottedand
probed for tRNA
Ser (UCN), tRNA
Gln, tRNA
Leu(UUR), tRNA
Val and for 5S rRNA.
Figure 3. Search for putative precursor transcripts by agarose gel electrophor-
esis and northern blotting. RNA isolated from three different cybrid clones
containing either mutation as well as from 143B cells and two control cybrid
cell lines were run, blotted and probed for ND1 and ND5/6 mRNAs as well as
for 18S rRNA. Positions of the respective mRNAs as well as the unprocessed
precursor transcript RNA19 are given.
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siderably. The upper band displays the same mobility as the
respective in vitro transcript and hence is considered as being
the unmodiﬁed (or a partially modiﬁed) tRNA. The in vitro
transcripts, which are cleaved by a ribozyme differ from the
in vivo tRNAs, besides the absence of modiﬁcations, by
the lack of a 50-phosphate group. Thus the mobility of
these transcripts were also compared before and after 50-
phosphorylation in a similar gel system and found to be
unchanged (Supplementary Figure 4).
The in vitro transcripts containing the G7497A mutation
migrated faster than transcripts of either wild-type sequence
or those containing the T7512C mutation. This indicates that
the C to U transition has a noticeable structural impact on the
RNA molecule per se while the T7512C mutation has no
apparent effect.
The second, faster moving band in all native tRNA samples
is considered to be the fully modiﬁed, mature tRNA. Interest-
ingly, the upper band corresponding to the incompletely
modiﬁed species is visible, but considerably less abundant in
T7512C tRNA and it is present, but barely visible in G7497A
tRNA when compared to wild-type controls (Figure 4B). This
strongly suggests that both mutations lead to a maturation
defect and instability of the unmodiﬁed isoform.
In order to support this new concept of several tRNA
isoforms existing at detectable levels during the maturation
process, we inhibited transcription and thus synthesis of the
unmodiﬁed isoform by treatment with EtBr and followed
recovery after EtBr withdrawal (Figure 5A and B). After
48 h of EtBr treatment (samples labelled 0 h), the mature
molecules, although decreased, are clearly more stable than
the unmodiﬁed species. This can be observed more easily in
control cells, but also in the mutant cell lines. During recovery
from the treatment, the unmodiﬁed species seems to accumu-
late to higher levels compared to the fully modiﬁed at early
time points, while the ratio between them is re-established
after 72 h of treatment.
Low molecular weight precursor transcripts suggest
a processing defect caused by the T7512C mutation
In addition, a similar blot of the same samples as in Figure 4A
revealed, after overexposure, several high molecular weight
bands hybridizing to the tRNA
Ser(UCN) probe (Supplementary
Figure 5). These bands were much less abundant than the
tRNA
Ser(UCN) molecules and were present only in clones con-
taining the T7512C mutation, but undetectable in the clones
harbouring the G7497A mutation.
Structuralprobingrevealsmildstructuralperturbances
only in the G7497A mutant
The structural effect of both mutations was investigated more
in detail by structural probing. Labelled in vitro transcripts
were submitted to limited digestion with different nucleases,
which are the probes of choice to detect major effects on
structure. Figure 6A shows a summary of cleavage patterns
A
B
Figure 4. Analysis of tRNA structure by non-denaturing PAGE and northern blotting. (A) Cybrid cell RNA. RNA isolated from three different cybrid clones
containing either mutation as well as from 143B cells and two control cybrid cell lines were run under non-denaturing conditions, blotted and probed for
tRNA
Ser(UCN), tRNA
Leu(UUR), tRNA
Val, tRNA
Gln and tRNA
Lys.( B) Cybrid cell RNA and in vitro transcribed tRNA. RNA samples used in (A) as well as in vitro
transcribed tRNA (underlined) were run under non-denaturing conditions, blotted and probed for tRNA
Ser(UCN). In this blot, only 1/10 of control cell RNA was
loaded in order to facilitate comparison of migration with the much less abundant tRNA
Ser(UCN) in cybrid clones.
Nucleic Acids Research, 2005, Vol. 33, No. 17 5653Figure 5. Degradation and synthesis of tRNA species following 48 h of treatment with EtBr and during a 72 h time course after EtBr withdrawal. Levels of tRNA
isoforms were analysed by non-denaturing PAGE and northern blotting. Lanes 1 and 2 contain RNA from untreated control (1/10 loaded) and mutant cell line,
respectively, 0 h samples were collected after 48 h of EtBr treatment before the recovery experiment started. (A) for G7497A mutation (B) for T7512C mutation.
AB
C
A
Figure 6. StructuralanalysisofinvitrotranscribedtRNAsbylimitednucleasedigestion.(A)SummaryofdigestionpatternsobtainedwithnucleasesT1,T2,V1,S1
for wild-type and tRNA
Ser(UCN) transcripts including both mutations (Boldface letters). Arrows indicate the cleavage points on the cloverleaf structure of
tRNA
Ser(UCN). The darkness of the arrows is proportional to the intensity of cuts, their shape indicate the nuclease used (see inset). Note that the first 5 nt from
eitherendarenotincludedintheanalysisfortechnicalreasons.ClosedcirclesindicatedifferencesinintensitiesofribonucleaseT1inducedcleavagesobservedinthe
G7497Amutant.(B)Structuralprobingofwild-typetRNA
Ser(UCN)andbothmutants.G:ribonucleaseT1cleavageunderdenaturingconditions;L:alkalinehydrolysis
ladder; C: control incubation of refolded tRNA under native conditions; 1–4: limited digestion under native conditions with the decreasing concentrations of
ribonuclease T1. Closed circles indicate differences in intensities of ribonuclease T1 induced cleavages observed in the G7497A mutant. Note that the apparent
differential migration of the T1 induced cleavage at G35 in the G7497A transcript is an artefact of electrophoresis. The respective bands of 30-labelled transcripts
comigrate at exactly the same level.
5654 Nucleic Acids Research, 2005, Vol. 33, No. 17obtained with RNases T1, T2 and nucleases S1 and V1 for all
transcripts. The cleavage patterns are consistent with the
expected cloverleaf structure (25) and the signals obtained
with RNases T1 and T2 are generally consistent with those
obtained on native fully modiﬁed tRNAs using the same
probes (11). Surprisingly, the cleavage patterns of the three
different transcripts were very similar and no large structural
alterations induced by either mutation are apparent from these
experiments. A closer investigation of the intensities of cleav-
ages induced by RNase T1 is shown in Figure 6B. Some local
changes near the mutation site and the anticodon in transcripts
containing the G7497A mutation are detected. These differ-
ences, which are indicated by black dots in Figure 6A and B,
were apparent in transcripts labelled on either extremity. No
signiﬁcant structural alterations were revealed in in vitro
transcribed tRNA
Ser(UCN) containing the T7512C mutation
(Figure 6B). The cleavage patterns obtained with RNAse
T2 and ribonucleases V1 and S1 are presented in Supplement-
ary Figure 6.
Mutations do not affect aminoacylation in
cybrid cell lines
We investigated the extent of aminoacylation of tRNA
Ser(UCN)
in cybrid cell lines using high resolution, acid urea PAGE and
northern blotting (Figure 7A and B). As control, an aliquot of
the 143B RNA-sample was deacylated. All cell lines contain
almost exclusively a tRNA
Ser(UCN) species migrating clearly
slower than the deacylated sample (Figure 7A). In order to
estimate the sensitivity of this method, we performed mixing
experiments using acylated and deacylated wild-type RNA
samples at various ratios (Figure 7B) and ﬁnd that at least
90% of the tRNA carries the amino acid. We conclude that
neither pathogenic mutation has a major detrimental effect on
aminoacylation efﬁciency. Hybridization of the same mem-
branes with probes speciﬁc for tRNA
Leu(UUR) and tRNA
Val
(Figure 7A) show that these tRNAs can be more easily sep-
arated into their non-acylated and acylated forms, and also that
these tRNAs are predominantly charged with amino acids.
Impairment of mitochondrial protein synthesis
Mitochondrial protein synthesis rate was assessed in cybrid
cells by pulse labelling with
35S-labelled methionine in the
presence of emetine under conditions in which incorporation
was linear over time (see Materials and Methods). Mitochon-
drial proteins in cybrid cells containing either mutation
showed a clearly reduced labelling compared to controls
(Figure 8A) indicating that protein synthesis rate is slowed
down. From a total of four independent experiments we cal-
culated that synthesis rates decreased to 68% and 58% of
control for the G7497A and T7512C mutation, respectively
(Figure 8B).
DISCUSSION
Pathogenic point mutations in tRNA
Ser(UCN) have been iden-
tiﬁed mainly in patients presenting with isolated deafness.
They showed almost invariably high levels of mutant
mtDNA, often close to or even reaching homoplasmy, thereby
indicating a high threshold for pathogenicity. We have studied
in osteosarcoma-derived cybrid cells the consequences of two
mutations, G7497A and T7512C, which have been identiﬁed
in patients with a more complex clinical picture, including
exercise intolerance, myoclonus epilepsy and deafness (12).
The G7497A mutation was also described in a young girl
presenting exclusively with exercise intolerance (26). How-
ever, deafness may still develop later in life in this patient,
since our patient with this mutation initially also presented
with exercise intolerance and fatigue only (12), but became
deaf later (unpublished data).
Regarding the responsible pathogenetic mechanisms, we
identiﬁed as a key ﬁnding severely reduced tRNA
Ser(UCN)
steady state levels below 10% for G7497A and T7512C in
osteosarcoma-derived cybrid cells harbouring either mutation
at near homoplasmic levels. A comparable marked depletion
was evidenced in the patients ﬁbroblasts (Figure 2). Reduced
steady state levels are not infrequent in various mutations of
mt tRNA genes, but so far, a similar dramatic decrease in
AB
Figure 7. Analysis of aminoacylation of tRNA
Ser(UCN) by acidic denaturing PAGE and northern blotting. (A) RNA isolated from 143B cells and from one cybrid
clone containing either mutation were run under acidic denaturing conditions, blotted and probed for tRNA
Ser(UCN), tRNA
Val, tRNA
Leu(UUR) and for 5S rRNA. A
sampleofdeacylatedRNAfrom143Bcellsobtainedbyalkalinetreatmentwasalsoloadedforcomparison.Only1/5ofRNAwasloadedfrom143Bcellsinorderto
facilitate comparison.(B) Mixing experiment using native and deacylatedwild-typeRNA samples at various ratios.For comparison the blot wasprobed as well for
tRNA
Leu(UUR).
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model studying a point-mutation in tRNA
Lys (27) and—in a
clinicalcontextfortRNA
Val—inalargefamilypresentingwith
multiple neonatal deaths (28). It remains puzzling how cells in
general and organisms in particular are able to tolerate such a
dramatic drop in the level of some mitochondrial tRNAs and,
at the same time, retain a basal capacity for protein synthesis,
in our cybrid cells still around 60% (Figure 8). Therefore our
cell lines make an excellent model system for future studies of
mechanisms behind the ability to survive under these condi-
tions, e.g. the stochiometric relationship of components of the
mitochondrial translation and protein assembly machinery, the
mtDNA haplotype or nuclear modiﬁer genes (29).
There are several reasons why tRNA
Ser(UCN) in particular
might be at risk for disturbances in processing, degradation
and post-transcriptional modiﬁcation. First, it is the rare
example ofa ‘stranded’ gene within the mitochondrial genome
(30) as the nearest encoded RNAs are located 7.2 kb upstream
and 1.6 kb downstream on the light strand, making the poly-
cistronic precursor transcript very long. This might conceiv-
ably commit precursor transcripts to a maturation pathway
different from that of heavy strand transcripts, which are
tightly packed with transcribed genes. The T7512C mutation
is transcribed into an A3G transition at the 50 end of the tRNA,
a location which makes it a likely candidate for misprocessing
by mitochondrial RNase P or other processing enzymes. The
recognition elements required for processing are poorly char-
acterized, however in analogy with bacterial as well as with
eukaryotic RNase P, the 50 ends of mt tRNAs might contain
important recognition signals (31,32). Indeed, light strand
transcripts indicative of a possible processing defect of a pre-
cursor were detected in cybrid cells containing the T7512C
mutation, but not in cells harbouring the G7497A mutation
(Supplementary Figure 5). However, they were much less
abundant and/or less stable than tRNASer(UCN) itself, as was
assumed before by Toompuu et al. (30). Therefore, this type of
processing defect is clearly different from the one seen in
patients carrying the A3243G and A3302G mutations in
tRNA
Leu(UUR) (33–35) and in corresponding cybrid models
(K. Maniura-Weber and R. J. Wiesner, unpublished data),
in which the heavy strand precursor RNA19 accumulates to
high abundance.
Second, tRNA
Ser(UCN) has an unusual structure with a short
connector region between the acceptor stem and the D-stem, a
relatively small D-loop, a 3 nt short variable loop and a long
6 bp anticodon stem [see (36) and (1) for a review on mt tRNA
structure]. The A3G transition resulting from the T7512C
mutation changes the wild-type A-U into a G-U base pair
within the acceptor stem, which however affects stability
only marginally. According to present knowledge on tRNA
structure, this change should at most induce a slight kink in the
acceptor helix, which is indeed consistent with our structural
probing data (Figure 6). The G7497A mutation results in a
C22U transition and an ensuing G-U base pair in the D-stem.
This is in close proximity to the two guanosines at positions
18 and 19, which form tertiary D-loop–T-loop interactions
(37,38) similar to those in cytosolic tRNAs. The mutation
might thus subtly inﬂuence the strength of these tertiary inter-
actions. Interestingly, a potentially similar situation has been
recently described for tRNALeu(CUN), where two alternative
T-stem alignments were found which may inﬂuence the
same set of tertiary interactions (39). Variations in those
same tertiary interactions in cytosolic tRNAs are known to
affectthe anglebetweenacceptorstem and anticodonstem and
have been experimentally shown to affect migration behaviour
in non-denaturing gels (40). This is at present the most plaus-
ible hypothesis to account for the differential migration beha-
viour displayed by the investigated tRNAs in such gels.
Indeed, non-denaturing gel electrophoresis of both, native
tRNA and in vitro transcripts, shows that the G7497A muta-
tion induces a structural change per se, namely a compaction
leading to faster electrophoretic mobility, while T7512C does
not (Figure 4B). Furthermore, this gel system identiﬁes two
tRNA species present in cybrid cells, namely a slow migrating
AB
Figure 8. Incorporationof[
35S]methionineintomitochondrial proteins.(A)Cellswereincubatedwith[
35S]methioninefor45minin thepresenceofemetine,lysed
and protein was separated by SDS–PAGE. Gels were dried and exposed to X-ray film. (B) Quantitative evaluation by densitometry of autoradiograms (n ¼ 4).
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scripts and a second, faster migrating population. These
probably correspond to unmodiﬁed (or partially modiﬁed)
molecules and mature tRNAs, respectively, which are the
fully modiﬁed molecules, at least in wild-type cells. In all
cell lines, post-transcriptional modiﬁcation leads to structural
compaction enhancing the mobility of the maturated tRNA to
about the same extent. Indeed, inhibition of de novo synthesis
of tRNAs by EtBr and release of this inhibition supports this
concept of a pool of unmodiﬁed tRNAs being converted into
the more stable, fully modiﬁed molecules (Figure 5A and B).
The identity of the base modiﬁcations responsible for com-
paction of the structure of tRNA
Ser(UCN) needs to be elucidated
in further studies. Native human mt tRNA
Ser(UCN) contains
four different modiﬁed nucleotides at ﬁve positions in the
tRNA structure (11). Because of their location in the structural
core, the pseudouridines 27 and 55 and ribothymidine 54 are
the most likely candidates to effect a structural rearrangement
as evidenced in our non-denaturing PAGE experiments.
Furthermore, the ratio between unmodiﬁed and maturated
populations is clearly altered in the clones incorporating both
mutations. While wild-type cells contain rather similar
amounts of both, the T7512C clones show preferentially,
the G7497A clones almost exclusively the faster migrating
isoform (Figure 4B). The amount of fully modiﬁed tRNAs
most likely is the result of a competition between maturation
by modifying enzymes and degradation by nucleases. We
hypothesize that both mutations lead to an impairment of
post-transcriptional modiﬁcation processes, ultimately leading
to a preponderance of degradation over maturation (41). Con-
sequently, the levels of maturated tRNA
Ser(UCN) molecules are
severely decreased.
However, the maturated tRNA
Ser(UCN) populations show no
major impairment of aminoacylation (Figure 7A). The second
serine isoacceptor in the mammalian mitochondrial genome,
tRNA
Ser(AGY) does not contain a D-domain. Furthermore, it
does not share any signiﬁcant sequence homologies with its
counterpart tRNASer(UCN), which raised the question how the
single mitochondrial seryl-tRNA synthetase (SerRS) recog-
nizes both of its cognate tRNAs. The T-domain was identiﬁed
as the region containing the major identity elements required
for tRNA serylation (42,43). The investigated mutations
T7512C and G4797A give rise to transitions A3G and
C22U, both of which are too remote from that domain to
signiﬁcantly affect aminoacylation. According to previous
investigations (43), the structural effect of the C22U mutation
on the tertiary interactions between D-loop and T-loop might
lead to a secondary impairment on aminoacylation. However
our in vivo data show no such evidence.
A number of studies have been devoted to investigate the
effects of pathogenic mutations on processing of mt tRNA
precursors and on aminoacylation using both, in vitro syn-
thesized tRNA and puriﬁed enzymes as well as cybrid cell
lines (30,44–46). So far, investigations regarding post-
transcriptional nucleotide modiﬁcation mostly focused on
wobble-base modiﬁcations in the anticodon loop, which affect
mRNA decoding (5,47,48). However, little attention has been
paid to maturation processes affecting tRNA structure and its
stability as a consequence of post-transcriptional modiﬁca-
tions. The present work establishes such a connection by
presenting a set of experimental data, which link structural
disturbance, post-transcriptional modiﬁcation events and a
high degree of tRNA instability in two tRNA
Ser(UCN) muta-
tions. Precise details of the pathogenic pathway of the T7512C
mutation remain to be further elucidated. The corresponding
cybrid cell lines make well suited models in further detailed
investigations to distinguish the factors discussed above as
causes and consequences in pathogenesis as well as for the
further study of mt tRNA stability and modiﬁcation.
In summary, our cybrids show that both mutations cause an
impairment of post-transcriptional maturation, leading to an
accelerated degradation of unmodiﬁed or partially modiﬁed
tRNAs. The T7512C mutation seems to cause an additional
processing defect, which could alone explain the low steady
state of the mature tRNA, but not the altered ratio between the
isoforms. These mechanisms lead to severely reduced steady
state levels of aminoacylated tRNA
Ser(UCN), causing a consid-
erable decrease of mitochondrial protein synthesis rate, ﬁnally
resulting in a severe biochemical defect of respiratory chain
function.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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